Quick Answer
Envoy Medical, Inc. reported Diluted EPS of $1.23 per share (loss) for fiscal year 2025.
Envoy Medical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.23 | +17.4% |
| 2024 | -$1.49 | +41.3% |
| 2023 | -$2.54 | -61.8% |
| 2022 | -$1.57 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.35 | +10.3% | -9.4% |
| June 30, 2025 | -$0.32 | -10.3% | -10.3% |
| March 31, 2025 | -$0.29 | +29.3% | +25.6% |
| September 30, 2024 | -$0.39 | -400.0% | -34.5% |
| June 30, 2024 | -$0.29 | +77.9% | +29.3% |
| March 31, 2024 | -$0.41 | +68.7% | -415.4% |
| September 30, 2023 | $0.13 | +200.0% | +109.9% |
| June 30, 2023 | -$1.31 | — | +0.0% |
- Envoy Medical, Inc. showed an increase of +17.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Envoy Medical, Inc.’s diluted eps has grown by 21.7% (from $1.57 per share (loss) to $1.23 per share (loss)).
- The most recent figure is from Envoy Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: